
CS-T-38566 ·
Clearsynth · Cat: CS-T-38566
Reach 3+ verified distributors
Manufacturer product page
clearsynth.com/product/CS-T-38566
Description
Palbociclib also known as compound number is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclindependent kinases CDK4 and CDK6.